Literature DB >> 9098411

HLA DR and DQ RFLP analysis in Crohn's disease.

R Wassmuth1, S Eastman, I Kockum, E Holmberg, M Starck, T Lindhagen, J R Kalden, A Lernmark, G Sundkvist, S Lindgren.   

Abstract

A study of 109 Swedish patients and 85 healthy Swedish controls with Crohn's disease (CD) by HLA class II RFLP genotyping was carried out. There was no significant association for any single DR or DQ specificity or phenotypic combination of DR and/or DQ specificities among our study group of Caucasian extraction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 9098411     DOI: 10.1111/j.1744-313x.1993.tb00162.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN: 0960-7420


  3 in total

1.  HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis.

Authors:  P C Stokkers; P H Reitsma; G N Tytgat; S J van Deventer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease.

Authors:  A Cariappa; B Sands; D Forcione; D Finkelstein; D K Podolsky; S Pillai
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

3.  Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease.

Authors:  Agnes Vatay; László Bene; Agota Kovács; Zoltán Prohászka; Csaba Szalai; László Romics; Béla Fekete; István Karádi; George Füst
Journal:  Immunogenetics       Date:  2003-06-14       Impact factor: 2.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.